Invention Grant
- Patent Title: Compounds and compositions as kinase inhibitors
-
Application No.: US15510613Application Date: 2015-09-11
-
Publication No.: US10392404B2Publication Date: 2019-08-27
- Inventor: Paul Andrew Barsanti , Matthew T. Burger , Yan Lou , Gisele A. Nishiguchi , Valery Rostislavovich Polyakov , Savithri Ramurthy , Sharadha Subramanian , Benjamin R. Taft , Huw Rowland Tanner , Lifeng Wan
- Applicant: NOVARTIS AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Scott W. Reid
- International Application: PCT/IB2015/056990 WO 20150911
- International Announcement: WO2016/038583 WO 20160317
- Main IPC: A61K31/444
- IPC: A61K31/444 ; C07D498/08 ; C07D401/14 ; C07D413/14 ; C07D213/74 ; C07D401/04 ; C07D401/10 ; C07D407/14 ; C07D411/14 ; C07D413/12 ; A61K31/4418 ; A61K31/496 ; A61K31/501 ; A61K31/5377 ; A61K31/541 ; C07D213/85 ; C07D405/12 ; C07D405/14 ; C07D451/02
Abstract:
The present invention provides compounds of Formula (I) and (II) as described herein, and salts thereof and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent.
Public/Granted literature
- US20170260200A1 COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS Public/Granted day:2017-09-14
Information query
IPC分类:
